静脉微波消融术后辅助柑橘黄酮的回顾性队列研究
该单中心回顾性队列纳入254例大隐静脉曲张患者,比较单纯静脉微波消融(EMA)与联合微粒化纯化黄酮组分(MPFF,2000 mg/d×2周)的短期结局。联合组临床应答率更高,症状评分、静脉血流速度及内皮生物标志物改善更优,6个月完全闭合率更高且残留反流更少,记录的不良事件无显著差异。
要点
- EMA术后辅助MPFF与2周临床应答及症状评分改善相关。
- 联合组静脉平均及峰值流速改善更明显,内皮生物标志物趋向改善。
- 6个月完全闭合率更高、残留反流更少,记录不良事件无显著增加。
核心结论
- EMA术后辅助柑橘黄酮与更好的早期症状评分、静脉血流动力学指标及内皮生物标志物谱相关,未发现记录不良事件增加。
- 研究为观察性设计且MPFF剂量非标准,结果应解读为关联而非因果、安全性证明或对2000 mg/d方案的支持。
研究设计与样本
- 单中心回顾性队列研究,纳入2022年1月至2025年7月治疗的254例大隐静脉曲张患者。
- 按实际治疗分组:单纯EMA组(n=126)与EMA联合MPFF组(n=128)。
- 联合组MPFF用法为1000 mg每日两次(2000 mg/d)持续2周,为静脉淋巴功能不全常用批准剂量的两倍。
主要发现
- 与单纯EMA相比,联合MPFF与更高的总体临床应答率及静脉临床严重程度评分、Aberdeen静脉曲张问卷、慢性静脉功能不全问卷评分更大改善相关(均P < .05)。
- 联合组平均及峰值静脉流速改善更明显(P < .05)。
- 联合组治疗后内皮素-1和循环内皮细胞水平更低、一氧化氮水平更高(P < .05)。
- 记录的不良事件两组间无显著差异(P > .05)。
- 6个月时联合组完全闭合率更高且残留反流更少(P < .05)。
关键数值与推荐
- 主要结局为2周时总体临床应答。
- 次要结局包括静脉临床严重程度评分、Aberdeen静脉曲张问卷、慢性静脉功能不全问卷、静脉血流动力学参数、探索性内皮生物标志物(如内皮素-1、一氧化氮、循环内皮细胞)、治疗相关不良事件及6个月超声发现。
临床怎么用
- 对于接受EMA的大隐静脉曲张患者,可考虑辅助柑橘黄酮以改善早期症状评分及静脉血流动力学,但需注意研究为观察性设计且剂量非标准。
- 因证据等级为关联性,不能据此常规推荐2000 mg/d的MPFF方案,临床决策应结合患者个体情况及批准剂量。
局限性
- 研究为单中心回顾性观察性设计,结果提示关联而非因果。
- MPFF使用非标准剂量(2000 mg/d,为常用批准剂量的两倍),限制了对该方案的推广。
- 需前瞻性随机试验采用批准剂量以确认 findings。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether adjunctive citrus flavonoids are associated with improved venous hemodynamics and short-term outcomes after endovenous microwave ablation (EMA) for great saphenous vein varicosis in a retrospective cohort. METHODS: This single-center retrospective cohort study included 254 patients with great saphenous vein varicosis treated between January 2022 and July 2025. Patients were grouped according to the actual treatment received: EMA alone (n = 126) or EMA plus micronized purified flavonoid fraction (MPFF; n = 128). In the combination group, MPFF was administered at 1000 mg twice daily (2000 mg/d) for 2 weeks; this was twice the usual approved dose for venolymphatic insufficiency. The primary outcome was overall clinical response at 2 weeks. Secondary outcomes included Venous Clinical Severity Score, Aberdeen Varicose Vein Questionnaire, Chronic Venous Insufficiency Questionnaire, venous hemodynamic parameters, exploratory endothelial biomarkers (such as endothelin-1, nitric oxide, and circulating endothelial cells), treatment-related adverse events, and 6-month ultrasound findings. RESULTS: Compared with EMA alone, adjunctive MPFF was associated with a higher overall clinical response and greater improvements in Venous Clinical Severity Score, Aberdeen Varicose Vein Questionnaire, and Chronic Venous Insufficiency Questionnaire scores (all P < .05). Mean and peak venous flow velocities improved more in the combination group (P < .05). The combination group also showed lower endothelin-1 and circulating endothelial cell levels and higher nitric oxide levels after treatment (P < .05). Recorded adverse events did not differ significantly between groups (P > .05). At 6 months, the combination group showed a higher rate of complete occlusion and less residual reflux (P < .05). CONCLUSIONS: In this retrospective cohort, adjunctive citrus flavonoids after EMA were associated with better early symptom scores, venous hemodynamic indices, and endothelial biomarker profiles without a detected increase in recorded adverse events. As the study was observational and used a nonstandard MPFF dose, these findings should be interpreted as associations rather than evidence of causality, proof of safety, or support for the 2000 mg/d regimen. Prospective randomized trials using approved dosing are needed to confirm these findings.
引用
- Rui Y, Chen W. Adjunctive citrus flavonoids after endovenous microwave ablation for great saphenous vein varicosis: A retrospective cohort study. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42521012. doi:10.1016/j.jvsv.2026.102586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。